tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP

Adaptimmune Therapeutics (ADAP) Ownership - Who Owns Adaptimmune Therapeutics?

725 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$17043494

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
38,974,185Institution15.25%45,989,538
10,787,022Institution4.22%12,728,686
1,485,464Institution0.58%1,752,848
397,665Institution0.16%469,245
139,636Institution0.05%164,770
130,170Institution0.05%153,601
117,909Institution0.05%139,133
99,822Institution0.04%117,790
73,922Institution0.03%87,228
41,764Institution0.02%49,282

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,485,464Institution0.58%1,752,848
130,170Institution0.05%153,601
117,909Institution0.05%139,133
99,822Institution0.04%117,790
73,922Institution0.03%87,228
25,396Institution<0.01%29,967
17,099Institution<0.01%20,177
16,913Institution<0.01%19,957
16,257Institution<0.01%19,183
10,080Institution<0.01%11,894

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
246,307Institution0.10%310,347
151,358Institution0.06%190,711
139,636Institution0.05%175,941
41,764Institution0.02%52,623
37,061Institution0.01%43,732

FAQ

Who Owns Adaptimmune Therapeutics (ADAP)?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
Christopher J. Burke owns the most shares of Adaptimmune Therapeutics (ADAP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis